Authors:
Saves, M
Morlat, P
Chene, G
Peuchant, E
Pellegrin, I
Bonnet, F
Bernard, N
Lacoste, D
Salamon, R
Beylot, J
Citation: M. Saves et al., Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy, CLIN IMMUNO, 99(3), 2001, pp. 347-352
Authors:
Bonnet, F
Saves, M
Droz, C
Peuchant, E
Chene, G
Beylot, J
Morlat, P
Citation: F. Bonnet et al., Increase of lipid plasma concentrations under protease inhibitor-containing regimens are not related to modifications of the tumour necrosis factor system, AIDS, 15(7), 2001, pp. 940-941
Authors:
Deschamps, V
Barberger-Gateau, P
Peuchant, E
Orgogozo, JM
Citation: V. Deschamps et al., Nutritional factors in cerebral aging and dementia: Epidemiological arguments for a role of oxidative stress, NEUROEPIDEM, 20(1), 2001, pp. 7-15
Authors:
Bourdel-Marchasson, I
Delmas-Beauvieux, MC
Peuchant, E
Richard-Harston, S
Decamps, A
Reignier, B
Emeriau, JP
Rainfray, M
Citation: I. Bourdel-marchasson et al., Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients, AGE AGEING, 30(3), 2001, pp. 235-241
Authors:
Bonnet, F
Saves, M
Droz, C
Peuchant, E
Chene, G
Beylot, J
Morlat, P
Citation: F. Bonnet et al., Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens, J ACQ IMM D, 25(2), 2000, pp. 199-200